![]() |
市場調査レポート
商品コード
1722629
プロバイオティクス市場レポート:成分、流通チャネル、用途、形態、地域別 2025-2033年Probiotics Market Report by Ingredient, Distribution Channel, Application, Form, and Region 2025-2033 |
||||||
カスタマイズ可能
|
プロバイオティクス市場レポート:成分、流通チャネル、用途、形態、地域別 2025-2033年 |
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
|
世界のプロバイオティクス市場規模は2024年に676億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに1,206億米ドルに達し、2025~2033年の成長率(CAGR)は6.3%を示すと予測しています。消化器系疾患の増加、機能性食品や飲食品の消費拡大、医薬品開発の拡大が市場の成長に影響を与えています。
主な市場促進要因消化器疾患の増加が市場の成長を促しています。また、健康とウェルネスに対する個人の意識の高まりが市場成長を後押ししています。
主要市場動向:高齢化人口の増加が、腸の健康と免疫機能を向上させるプロバイオティクスの需要を牽引しており、それによって市場の見通しは良好です。また、機能性食品や飲食品の消費の増加が市場の成長を刺激しています。
地理的動向:アジア太平洋地域は、高齢化とともに消化器系疾患の有病率が増加しているため、最大のセグメントを占めています。
競合情勢:プロバイオティクス業界の主な市場プレイヤーは、Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd., その他、です。
課題と機会:市場は、プロバイオティクス市場の収益や需給の不均衡に影響を与える激しい競合や市場の飽和といった課題に直面する一方で、主要企業がプロバイオティクスをより効率的かつ大量に生産できる生産技術の開拓という機会にも遭遇しています。
機能性食品への需要の高まり
IMARC Groupのレポートによると、世界の機能性食品市場規模は2023年に2,211億米ドルに達し、2032年には3,689億米ドルに達すると予測されています。プロバイオティクス市場の重要な促進要因のひとつは、機能性食品に対する需要の高まりです。消費者は、栄養に加えて健康上のメリットを提供できる飲食品への関心を高めています。プロバイオティクス付き製品を含む機能性食品は、身体の機能をサポートし、病気を予防するための重要な供給源と考えられています。第二に、腸の健康の重要性に関する個人の健康意識と意識の高まりが、この需要を後押ししています。人々は、全体的な健康状態における腸内細菌叢の役割について知識を深めているため、消化器系に有益な製品を購入することを熱望しています。プロバイオティクスは、腸内細菌叢のバランスを整えて腸内環境を改善する天然製品であるため、健康志向の消費者の間で人気を博しています。
医薬品開発の拡大
プロバイオティクスの作用機序や治療可能性を解明するための調査が進むにつれ、その有効性を証明するための質の高い臨床試験を実施する必要性が高まっています。新薬の開発には、臨床的に検証されたプロバイオティクス菌株の特定の健康状態の治療における安全性と有効性を実証するランダム化比較試験を実施することが必要です。これらの臨床試験は、プロバイオティクスの治療薬としての使用を支持する科学的証拠を生み出し、それによって消費者の信頼を高め、プロバイオティクス市場の成長を促進します。さらに、主な企業はプロバイオティクスの医薬品開発に投資する一方、新規プロバイオティクス菌株、製剤、治療用途の特許保護取得に注力しています。さらに、行政機関は製剤の安全性と安定性を重視しています。また、世界中で医薬品開発や抗生物質の製造に投資しています。例えば、保健福祉省は2022年、医薬品有効成分(API)と抗生物質のバイオ製造の役割を拡大するために4,000万米ドルを投資しました。
動物飼料産業の繁栄
IMARC Groupの報告書によると、世界の動物飼料市場は2032年までに6,747億米ドルに達すると予想されています。家畜や家禽だけでなく、ペットにおいても、動物の腸内環境の有効性が認識されるようになってきています。ヒトと同様、腸内細菌叢は消化、栄養摂取、免疫反応、一般的な健康状態に影響を与えるなど、動物の健康を左右する上で不可欠です。そのため、動物生産者やペットオーナーは、腸の健康や動物のパフォーマンス向上のために、プロバイオティクスをアニマルフードに使用するケースが増えています。プロバイオティクスは、開発アプローチの持続可能な性質に加え、飼料効率の向上と栄養素の利用率に起因する胃腸障害の軽減にも関連しています。また、プロバイオティクスは動物生産生態学の生産性と持続可能性を高めるために活用することができます。
The global probiotics market size reached USD 67.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 120.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.3% during 2025-2033. Rising digestive issues, the growing consumption of functional food and beverages, and expansion of drug development is impacting the growth of the market.
Major Market Drivers: The rising number of digestive disorders is impelling the growth of the market. Additionally, the increasing awareness among individuals about health and wellness is bolstering the market growth.
Key Market Trends: The growing aging population is driving the demand for probiotics to improve gut health and immune function, thereby offering a favorable market outlook. In addition, an increase in consumption of functional food and beverages is stimulating the market growth.
Geographical Trends: Asia Pacific holds the largest segment because of the growing prevalence of digestive issues, along with the rising aging population.
Competitive Landscape: Some of the major market players in the probiotics industry include Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd., among many others.
Challenges and Opportunities: While the market faces challenges like intense competition and market saturation, which impacts probiotics market revenue and supply-demand imbalances, it also encounters opportunities in the development of production technologies that allows key players to produce probiotics more efficiently and substantially.
Growing Demand for Functional Food
According to the IMARC Group's report the global functional food market size reached US$ 221.1 Billion in 2023 and expected to reach US$ 368.9 Billion by 2032. One of the significant drivers of the probiotics market is the growing demand for functional foods. Consumers are becoming more interested in food and beverages that can provide health benefits in addition to nutrition. Functional foods, which include products with probiotics, are considered an important source to support the functions of body and prevent disease. Secondly, an increase in health consciousness and awareness among individuals about the importance of gut health is driving this demand. As people are becoming more informed about the role of gut microbiota in overall well-being, they are eager to buy products that benefit their digestive system. Probiotics are a natural product that rebalances the microbiota to improve the gut, thus gaining popularity among health-conscious consumers.
Expansion of Drug Development
Growing research to elucidate the modes of action and therapeutic potential of probiotics is leading to the growing need for conducting high-quality clinical trials to prove their efficacy. Developing a new drug entail running randomized controlled trials that demonstrate the safety and efficacy of clinically validated probiotic strains in treating specific health conditions. These clinical studies generate scientific evidence that supports the use of probiotics as therapeutic agents, thereby boosting consumer confidence and driving probiotics market growth. Moreover, key players are investing in drug development for probiotics while focusing on obtaining patent protection for novel probiotic strains, formulations, and therapeutic applications. In addition, governing agencies are emphasizing the safety and stability of formulation. They are also investing in the manufacturing of drug development and antibiotics across the globe. For example, the Department of Health and Human Services invested $ 40 million in 2022 to expand the role of biomanufacturing for active pharmaceutical ingredients (APIs) and antibiotics.
Thriving Animal Feed Industry
The IMARC Group's report shows that the global animal feed market is expected to reach US$ 674.7 Billion by 2032. Increasingly, people are becoming aware about the viability of animal gut health, not just in livestock and poultry but also in pets. As in humans, the microbiota of the gut is essential in influencing animal health by impacting digestion, nutrient uptake, immune response, and general well-being among other roles. Consequently, animal producers and pet owners are increasingly adopting the use of probiotics in animal food for gut health and overall improvement of animal performance. Probiotics are likewise associated with the reduction of gastrointestinal disorders attributable to enhanced feed efficiency and utilization of nutrients, in addition to the sustainable nature of the development approach. Also, probiotics can be utilized to enhance the productivity and sustainability of animal production ecology.
Bacteria accounts for the majority of the market share
Bacteria have been widely researched and studied for their health benefits in relation to gut health. Bacteria like Lactobacillus and Bifidobacterium species are known for their ability to promote a healthy balance of microbiota, which is essential for digestion, nutrient absorption, and immune function. In addition, bacteria are easy to incorporate into various products like dairy products, dietary supplements, and functional foods. The well-established research is supporting the health benefits of bacterial probiotics, which is boosting the growth of the segment
Supermarkets and hypermarkets hold the largest share of the industry
Supermarkets and hypermarkets offer a broad variety of probiotic products from different brands, providing people with ample choices to suit their preferences and needs. The convenience of these stores attracts a large number of people seeking probiotics supplements and food and beverage products. Additionally, they leverage promotional strategies like discounts, special offers, and product placements to expand sales and encourage repeat purchases. Their established distribution networks also allow efficient supply chain management, ensuring consistent availability of probiotics products across the globe.
Food and beverages represent the leading market segment
The incorporation of probiotics into food and beverage products offer a convenient way for consumers to take these beneficial microorganisms into their daily diet, along with the rise in hectic working schedules of people that is encouraging the adoption of ready-to-eat (RTE) meals in which probiotics are included, such as yogurt cups, snack bars, cereal, and beverages, making it easy for people to access the health benefits of probiotics without the need for additional supplementation.
Liquid exhibits a clear dominance in the market
The liquid probiotics offer a convenient and easy-to-consume formats for probiotics, making them accessible to a broad range of consumers. These probiotics are available in various forms like drinks, shots, and concentrates, allowing people to incorporate them into their daily routines. Moreover, these probiotics have faster absorption rate compared to other forms. They also allow greater flexibility in formulations, enabling key players to create products with diverse probiotic stains and functional ingredients to target specific health issues.
Asia Pacific leads the market, accounting for the largest probiotics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific represents the largest regional market for probiotics.
The growing awareness among the masses about the benefits of probiotics is strengthening the growth of the market across the region. Moreover, rising disposable income of people in countries like China, Japan, and South Korea are driving the demand for probiotic supplements and functional foods to improve digestive health and overall wellness. In addition, governing agencies are undertaking initiatives to promote the use of probiotics in food and beverage products, which is further bolstering the market growth in the region. Besides this, the growing understanding of the importance of preventive health with several studies showing the benefits of these products on immunity, cognitive health, and skincare, along with rising aging population, is catalyzing the probiotics demand. The State Council report of the People's Report of China 2021 shows that the total population of Chinese people on the mainland aged 60 or above has reached 264.02 million, including 190.64 million people aged 65 or above.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major probiotics companies have also been provided. Some of the major market players in the probiotics industry include Biogaia AB, Chr. Hansen Holding A/S, Danone S.A., General Mills Inc, i-Health Inc (Koninklijke DSM N.V.), Kerry Group plc, Lallemand Inc., Lifeway Foods Inc, Morinaga Milk Industry Co. Ltd., Nestle S.A., PepsiCo Inc, Probi (Symrise AG) and Yakult Honsha Co.Ltd.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Key players are investing in research and development (R&D) activities to identify new probiotics strains, enhance formulations technologies, and better understand the mechanisms of action and health benefits of probiotics. They are also working with research institutes and healthcare organizations to develop the probiotics products. Moreover, companies are prioritizing quality assurance and control measures to ensure stability and safety of their probiotics products. Key manufacturers are also expanding their product lines to include a broad variety of probiotic formulations targeting different consumers. For instance, in 2021, Lifeway Foods, Inc., the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, announced its new line of dairy-free probiotic oat beverage at natural products expo east.